Telix Pharmaceuticals Limited (ASX:TLX)
Australia · Delayed Price · Currency is AUD 14.91
-0.70 (-4.48%)
Jul 17, 2026, 4:11 PM AEST
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 5.07 billion as of July 17, 2026. Its market cap has decreased by -37.70% in one year.
Market Cap
5.07B
Enterprise Value
5.55B
Revenue
1.21B
Ranking
n/a
PE Ratio
n/a
Stock Price
14.91
ChartMarket Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 5.07B, an increase of 3,232.43%. That is a compound annual growth rate of 49.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 5.07B | 33.54% |
| Dec 31, 2025 | 3.79B | -53.95% |
| Dec 31, 2024 | 8.24B | 152.44% |
| Dec 29, 2023 | 3.26B | 41.89% |
| Dec 30, 2022 | 2.30B | 4.10% |
| Dec 31, 2021 | 2.21B | 108.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 58.31B |
| Mesoblast | 3.36B |
| Neuren Pharmaceuticals | 2.22B |
| PYC Therapeutics | 1.59B |
| Clarity Pharmaceuticals | 914.05M |
| Clinuvel Pharmaceuticals | 503.27M |
| Racura Oncology | 436.10M |
| Tetratherix | 372.45M |